Phenytoin and St. John's Wort: Can You Take Them Together?

High — Consult Your Doctorconflict
Learn about each ingredient:PhenytoinSt. John's Wort

Quick answer

St. John's Wort activates the pregnane X receptor and induces drug-metabolizing enzymes (CYP3A4, CYP2C9, CYP2C19) and P-glycoprotein. Because phenytoin is cleared mainly by CYP2C9 and CYP2C19, taking St. John's Wort alongside it could speed phenytoin's breakdown and lower its blood levels, raising the theoretical risk of breakthrough seizures. Direct human data for phenytoin specifically are limited, so regulators treat this as a mechanism-based precaution rather than a documented loss of control.

Avoid combining St. John's Wort with phenytoin, since the herb can speed phenytoin's breakdown and risk breakthrough seizures. If you already take both, do not stop the herb abruptly because levels can rebound; review with your doctor or pharmacist before making any change.

What happens?

Phenytoin is a seizure medicine with a narrow therapeutic window, and St. John's Wort is a powerful inducer of the very liver enzymes that clear it. Taking them together can speed phenytoin's breakdown and pull its blood levels down.

1

Enzyme switch

St. John's Wort's active constituent hyperforin activates the pregnane X receptor (PXR), a master switch that ramps up production of the body's drug-metabolizing machinery.

2

Faster clearance

Activated PXR increases CYP2C9 and CYP2C19, the same enzymes that break down phenytoin. With more of those enzymes, the liver can clear phenytoin faster than before, dragging its blood level down.

3

Slow on and off

This induction builds over one to two weeks of regular use and fades over a similar period after the herb is stopped, so levels can drift down on the way in and back up on the way out.

Direct human evidence for phenytoin specifically is <strong>limited</strong> — this is a mechanism-based precaution grounded in well-established enzyme induction, not a documented clinical failure.

Why is this important?

A few features of phenytoin make caution sensible even when the human data are thin, because the worst-case outcome is serious and hard to predict.

Non-linear kinetics

Phenytoin has saturable kinetics, so near saturation small changes in metabolism can produce larger-than-expected swings in blood level in either direction, making any outside influence harder to manage.

Breakthrough seizure

Losing seizure control is not just a missed lab target. A breakthrough seizure can cause injury from a fall, a road accident, or other harm, so the worst-case outcome is high even if the chance is uncertain.

Rebound on stopping

Stopping the herb abruptly lets the induced enzymes return to baseline and phenytoin levels climb again, especially if a dose was raised while the herb was on board.

'Natural' is not 'safe'

St. John's Wort is sold over the counter for low mood, anxiety, and sleep, and its interaction profile is real and well-documented, deserving the same caution as a prescription medicine.

Regulators including the UK MHRA list antiepileptics among the drugs St. John's Wort may interfere with.

Which specific products are affected?

Many common St. John's Wort products can affect this interaction.

Phenytoin products (all forms)

Dilantin (capsules, chewable tablets, oral suspension)Phenytek (extended-release capsules)Generic phenytoin sodium capsules and tabletsIntravenous phenytoin used in hospital settingsFosphenytoin (Cerebyx), a prodrug converted to phenytoin

St. John's Wort products to keep separate

Standardized St. John's Wort capsules and tabletsSt. John's Wort teas and tincturesCombination 'mood support' or 'calm' herbal blends containing Hypericum perforatum

Other sources

  • Low-hyperforin extracts marketed as having fewer interactions

The induction effect tracks with hyperforin content, but with a narrow-index anticonvulsant the prudent approach is to treat any St. John's Wort product as one to keep separate from phenytoin.

The bottom line

St. John's Wort induces the liver enzymes (CYP2C9, CYP2C19) that clear phenytoin, so it could lower phenytoin levels and risk breakthrough seizures. The mechanism is well established even though phenytoin-specific human evidence is limited, so the recommendation is to avoid the combination given phenytoin's narrow therapeutic index. If you already take both, do not stop the herb abruptly on your own, because levels can rebound as the enzyme effect wears off.

Plan any change with your doctor or pharmacist, who may want to recheck a phenytoin level and adjust the dose.

What happens when you take phenytoin with st. john's wort?

Phenytoin (brand names Dilantin and Phenytek) is an older anticonvulsant with a narrow therapeutic index. That phrase means there is only a small gap between a blood level that controls seizures and one that causes side effects such as unsteadiness, double vision, and confusion. Phenytoin is cleared mainly by the liver enzymes CYP2C9 and CYP2C19. St. John's Wort (Hypericum perforatum) is one of the strongest herbal inducers of those same enzymes. Here is the chain of events behind the concern:

  1. St. John's Wort's active constituent hyperforin activates the pregnane X receptor (PXR), a master switch that turns up production of drug-metabolizing machinery.
  2. Activated PXR increases the amount of CYP3A4, CYP2C9, CYP2C19, and the P-glycoprotein efflux pump your body makes.
  3. Because phenytoin is broken down by CYP2C9 and CYP2C19, more of those enzymes means your liver can clear phenytoin faster than before.
  4. Faster clearance can pull phenytoin blood levels down, and if they fall far enough, seizure control could be lost.
  5. This induction builds over one to two weeks and fades over a similar period after the herb is stopped, so levels can also drift back up later.

It is worth being honest about the strength of the evidence. The induction mechanism is well established, and regulators including the UK MHRA list antiepileptics among the drugs St. John's Wort may interfere with. But direct human or case-report data showing phenytoin levels actually dropping or seizures actually breaking through are sparse for phenytoin specifically. This is a mechanism-based precaution, not a heavily documented clinical failure, which is why "avoid" is recommended even though the real-world frequency is not well characterized.

Why is this important?

A few features of phenytoin make caution sensible even when the human data are thin.

First, phenytoin has non-linear (saturable) kinetics. Near saturation, small changes in dose or metabolism can produce larger-than-expected swings in blood level in either direction. That makes any outside influence on clearance harder to predict and manage.

Second, the consequence of losing seizure control is not just a missed lab target. A breakthrough seizure can lead to injury from a fall, a road accident, or other harm, so the seriousness of the worst-case outcome is high even if the chance is uncertain.

Third, the effect is time-shifting. Starting the herb can lower phenytoin levels over a week or two; stopping it lets them rise again as the induced enzymes return to baseline. If a dose was raised while the herb was on board, stopping the herb abruptly could let levels climb. That is why cold-turkey discontinuation without a plan is discouraged.

Finally, St. John's Wort is sold over the counter for low mood, anxiety, and sleep, and many people assume "natural" means "safe with my prescriptions." Its interaction profile is real and well-documented for several drug classes, so it deserves the same caution you would give a prescription medicine.

What should you do?

The simplest safe path is to keep these two separate and to make any change with your prescriber rather than on your own.

Before changing anything: If you take phenytoin, the straightforward move is not to start St. John's Wort. If you are already taking both, tell your prescriber or pharmacist before you alter either one. Ask whether checking a phenytoin level makes sense for your situation.

Day to day while both are on board: Do not stop the herb suddenly on your own. Stay alert for signs that seizure control may be slipping, and for phenytoin side effects such as unsteadiness or double vision, and report changes promptly.

When you stop the herb: Plan it with your prescriber rather than quitting abruptly, because phenytoin levels can drift back up as the herb's enzyme effect wears off over a week or two. Your clinician may want to recheck a level and adjust the dose during that window.

If you have epilepsy and want help with low mood, ask your prescriber about treatment options that can be used alongside phenytoin with appropriate monitoring, rather than reaching for an herbal product on your own.

Which specific products are affected?

On the medication side, the concern applies to phenytoin in all its forms:

  • Dilantin (capsules, chewable tablets, oral suspension)
  • Phenytek (extended-release capsules)
  • Generic phenytoin sodium capsules and tablets
  • Intravenous phenytoin used in hospital settings
  • Fosphenytoin (Cerebyx), a prodrug converted to phenytoin in the body

On the supplement side, the concern applies to St. John's Wort in essentially any form with meaningful hyperforin content:

  • Standardized St. John's Wort capsules and tablets
  • St. John's Wort teas and tinctures
  • Combination "mood support" or "calm" herbal blends that contain Hypericum perforatum

Low-hyperforin extracts have been marketed as having fewer interactions, but with a narrow-index anticonvulsant the prudent approach is to treat any St. John's Wort product as one to keep separate from phenytoin.

The science behind it

The evidence here is strong on mechanism and lighter on phenytoin-specific outcomes.

  • MHRA Drug Safety Update (2014), "Herbal ingredient St John's wort may interact with antiepileptics." A regulatory safety communication advising that St. John's Wort can reduce blood levels of antiepileptic drugs and should generally be avoided in people taking them. gov.uk
  • Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. "St John's wort (Hypericum perforatum): drug interactions and clinical outcomes," review (Br J Clin Pharmacol / PMC1874438). A review describing how St. John's Wort constituents induce CYP enzymes (including CYP3A4 and CYP2C9) and P-glycoprotein, with the underlying induction mechanism linked to pregnane X receptor activation; the phenytoin interaction is presented on a pharmacokinetic, mechanism-based footing rather than from direct phenytoin trials. PMC1874438

Taken together, these sources support a precautionary "avoid" recommendation grounded in a well-characterized induction mechanism, while being candid that documented phenytoin-specific clinical events are limited.

Frequently Asked Questions

Will St. John's Wort definitely make my phenytoin stop working?

No. The mechanism makes lower phenytoin levels plausible, but direct evidence of seizures breaking through on this specific combination is limited. The recommendation to avoid it is precautionary because the potential downside is serious, not because failure is guaranteed.

Why avoid it if the human data are thin?

Because the worst-case outcome is a seizure and phenytoin has unpredictable, non-linear kinetics, the consequences of being wrong are high. When a serious outcome is possible and a safer alternative exists, regulators favor caution.

Can I just stop the St. John's Wort myself?

It is better to plan it with your prescriber. The herb's enzyme effect fades over a week or two, so phenytoin levels can drift back up after you stop, especially if a dose was adjusted while you were taking the herb.

Does the form of St. John's Wort matter?

The induction effect tracks with hyperforin content, so higher-hyperforin extracts are of greater concern. With a narrow-index drug like phenytoin, the safest approach is to treat all forms as ones to keep separate.

I take St. John's Wort for low mood and also have epilepsy. What are my options?

Ask your prescriber about mood treatments that can be used alongside phenytoin with monitoring. Your neurologist and primary care provider can coordinate a plan that does not rely on the herb.

How long does it take for the interaction to build up or wear off?

Enzyme induction from St. John's Wort generally develops over one to two weeks of regular use and takes a similar period to fade after stopping. That is why both starting and stopping the herb deserve a plan.

Key takeaways

  • St. John's Wort induces the liver enzymes (CYP2C9, CYP2C19) that clear phenytoin, so it could lower phenytoin levels and risk breakthrough seizures.
  • The mechanism is well established; phenytoin-specific human evidence is limited, so this is a precaution, not a documented failure.
  • The recommendation is to avoid the combination, given phenytoin's narrow therapeutic index and the seriousness of a seizure.
  • Do not stop the herb abruptly on your own, levels can rebound, plan changes with your doctor or pharmacist.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Phenytoin + Ginkgo

high

Ginkgo biloba can induce CYP2C19, an enzyme involved in clearing phenytoin, which may lower phenytoin blood levels and raise the risk of breakthrough seizures. A published fatal case report described subtherapeutic phenytoin and valproate levels in a patient who had been self-administering ginkgo. Ginkgo also carries its own seizure-related signal. If you take phenytoin, avoid ginkgo and review any supplement changes with your doctor or pharmacist.

Digoxin + St. John's Wort

high

St. John's wort revs up a gut transporter that digoxin depends on for absorption, so combining them quietly drains digoxin from the bloodstream. Because digoxin has so little room to spare, that drop can leave the drug too weak to control your heart.

Adderall + St. John's Wort

high

Adderall (mixed amphetamine salts) raises synaptic norepinephrine, dopamine, and to a lesser extent serotonin. St. John's Wort inhibits reuptake of those same monoamines. Together they can push the serotonergic system far enough to risk serotonin syndrome and can add cardiovascular strain. Separately, St. John's Wort strongly induces the CYP3A4 enzyme and P-glycoprotein, which can blunt the effect of many co-taken medicines.

Methylphenidate + St. John's Wort

moderate

Methylphenidate treats ADHD by inhibiting reuptake of dopamine and norepinephrine. St. John's Wort adds its own monoamine reuptake activity and is a strong inducer of the CYP3A4 drug-metabolising enzyme. A small published observation suggests St. John's Wort can blunt methylphenidate's effect on ADHD symptoms. There is also a theoretical, additive serotonergic risk, mainly relevant if other serotonergic drugs are present, but no confirmed serotonin syndrome cases have been reported for this specific pair.

Verapamil + St. John's Wort

high

St. John's wort is a potent inducer of intestinal CYP3A4 and P-glycoprotein, the same enzymes that break down verapamil before it reaches the bloodstream. Taking the two together sharply lowers verapamil's systemic exposure and can erase its therapeutic effect on blood pressure, heart rhythm, or migraine prevention.

Sertraline + St. John's Wort

critical

Sertraline is an SSRI that blocks serotonin reuptake, and St. John's wort independently raises central serotonin through constituents such as hyperforin and hypericin. Combining them can trigger serotonin syndrome, a potentially life-threatening reaction marked by altered mental status, autonomic instability, and neuromuscular hyperactivity. St. John's wort also induces CYP3A4 and CYP2C19, which can lower sertraline levels and undermine treatment.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free